Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

about

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

Item

http://www.wikidata.org/entity/Q36187641

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

@ast

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

@en

type

Item

label

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

@ast

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

@en

prefLabel

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

@ast

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

@en

P1476

Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women.

@en

P2093

Alice Stek

http://www.w3.org/2001/XMLSchema#string

Angela Colbers

http://www.w3.org/2001/XMLSchema#string

Annette Haberl

http://www.w3.org/2001/XMLSchema#string

Brookie Best

http://www.w3.org/2001/XMLSchema#string

Carmen Hidalgo Tenorio

http://www.w3.org/2001/XMLSchema#string

David Burger

http://www.w3.org/2001/XMLSchema#string

David Hawkins

http://www.w3.org/2001/XMLSchema#string

Edmund Capparelli

http://www.w3.org/2001/XMLSchema#string

Graham Taylor

http://www.w3.org/2001/XMLSchema#string

Jiajia Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Maternal-fetal pharmacokinetics and dynamics of a single intrapartum dose of maraviroc in rhesus macaques

Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011.

Drugs in pregnancy. Pharmacokinetics in pregnancy.

Reviews of anti-infective agents: maraviroc: the first of a new class of antiretroviral agents.

Pharmacokinetic interactions of maraviroc with darunavir-ritonavir, etravirine, and etravirine-darunavir-ritonavir in healthy volunteers: results of two drug interaction trials.

Designing drug trials: considerations for pregnant women.

Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach.

Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratories.

Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.

Once daily maraviroc 300 mg or 150 mg in combination with ritonavir-boosted darunavir 800/100 mg.

P304

1582-1589

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIV587

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Regis Kreitchmann

Elizabeth Smith

P577

2015-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26202768

http://www.w3.org/2001/XMLSchema#string

P932

4614410

http://www.w3.org/2001/XMLSchema#string